1-3 of 3
Isabella Schiller
Close
Sort by
Journal Articles

IL23R Arg381Gln Variant in the Donor Confers Strong Protection Against Acute Graft-Versus Host Disease after Hematopoietic Stem Cell Transplantation in Children with Hematological Malignancies.

Bernd Gruhn, MD, Juliane Intek, Nadine Pfaffendorf, Susan Wittig, Ilona Wolff, Isabella Schiller, Astrid Voigt, PhD, Ralf Häfer, PhD, Dietlinde Fuchs, MD, Felix Zintl, MD
Journal: Blood
Blood (2007) 110 (11): 2987.
https://doi.org/10.1182/blood.V110.11.2987.2987
Published: 2007
Journal Articles

The Impact of Disease Status at Transplant and Time to First Relapse on Outcome in Children and Adolescents with Hodgkin’s Lymphoma Undergoing Autologous Stem Cell Transplantation.

Alexander Claviez, MD, Hartmut Kabisch, MD, Meinolf Suttorp, MD, Christina Peters, MD, Barbara Hero, MD, Isabella Schiller, Wolfgang Doerffel, MD, Norbert Schmitz, MD, Felix Zintl, MD
Journal: Blood
Blood (2004) 104 (11): 1878.
https://doi.org/10.1182/blood.V104.11.1878.1878
Published: 2004
Journal Articles

Different Epstein-Barr Virus DNA Load and Immune Reconstitution Following Hematopoietic Stem Cell Transplantation Depending on Antithymocyte Globulin Preparation.

Bernd Gruhn, MD, Astrid Meerbach, MD, Ralf Häfer, PhD, Ilona Wolff, Isabella Schiller, Dietlinde Fuchs, MD, Johann Hermann, MD, Peter Wutzler, MD, Felix Zintl, MD
Journal: Blood
Blood (2004) 104 (11): 5081.
https://doi.org/10.1182/blood.V104.11.5081.5081
Published: 2004